Physician profile
Alina E Hedberg
NPI 1326409517
$555.29
in general payments reported to CMS, 2019-2025
14 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $68.80 · 2024: $197 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $98.43 | 2023-2025 | |
| Amgen INC. | $65.56 | 2024-2025 | Evenity, Prolia, Prolia |
| Abbott Laboratories | $63.86 | 2023-2024 | Freestyle Libre 3 |
| Novo Nordisk INC | $47.86 | 2025 | Wegovy, Rybelsus, Ozempic |
| Astellas Pharma US INC | $45.18 | 2024-2025 | Veozah |
| Lilly USA, LLC | $43.71 | 2023-2025 | Mounjaro, Zepbound |
| Dynavax Technologies Corporation | $37.93 | 2024-2025 | Heplisav-B |
| Sanofi-Aventis U.S. LLC | $29.71 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $27.46 | 2023-2024 | Farxiga, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $24.29 | 2025 | |
| Axsome Therapeutics, INC. | $23.82 | 2025 | Auvelity |
| Eisai INC. | $16.81 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.09 | 2025 | Xifaxan |
| Lundbeck LLC | $14.58 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alina Hedberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.